Inoviq (ASX:IIQ) Net Issuance of Preferred Stock : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is Inoviq Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Inoviq's net issuance of preferred for the six months ended in Dec. 2023 was A$0.00 Mil. The number is 0, which means that Inoviq has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Inoviq's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Inoviq Net Issuance of Preferred Stock Historical Data

The historical data trend for Inoviq's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq Net Issuance of Preferred Stock Chart

Inoviq Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Inoviq Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Inoviq Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Inoviq Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Inoviq's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Inoviq (ASX:IIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168

Website

https://www.bard1.com

Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq (ASX:IIQ) Headlines

No Headlines